Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 32.6B | 0.8% |
| Gross Profit | 32.6B | 0.8% |
| Operating expense | 32.5B | 2.7% |
| Net Income | 195M | 64.2% |
| EBITDA | 480M | 56.7% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 49.7B | 1.3% |
| Total Liabilities | 31.1B | 2.9% |
| Total Equity | 18.5B | 1.6% |
| Shares Outstanding | 121M | 0% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 971M | 23.6% |
| Cash from investing | 980M | 182.4% |
| Cash from financing | -603M | 67% |
EPS
Financial Highlights for Humana in Q3 '25
Humana reported a revenue of 32.6B, which is a 0.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 32.6B, marking a 0.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Operating Expenses for this period were 32.5B, showing a 2.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 195M, showing a -64.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 480M, showing a -56.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Humana faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
